Complement and microglia mediate early synapse loss in Alzheimer mouse models
Open accessThe DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index; 21 of the 28 sources its claims cite were checked for support.
Abstract
Too much cleaning up: The complement system and microglia seek out and destroy unwanted cellular debris for the peripheral immune system as well as excess synapses in the developing brain. Hong et al. now show how the system may go haywire in adults early in the progression toward Alzheimer's disease (AD). Aberrant synapse loss is an early feature of Alzheimer's and correlates with cognitive decline. In mice susceptible to AD, complement was associated with synapses, and microglial function was required for synapse loss. The authors speculate that aberrant activation of this “trash disposal” system underlies AD pathology. Science , this issue p. 712
Overview
CoChat Summary
TL;DR
In Alzheimer mouse models, classical complement proteins C1q and C3 increase and localize to synapses before plaques, and blocking C1q, C3, or microglial CR3 reduces early synapse loss. Soluble Aβ oligomers drive microglial engulfment of synaptic material through a CR3-dependent pathway, suggesting reactivation of developmental synaptic pruning in early AD.
Key findings
- J20 hAPP mice showed significant hippocampal synapse loss at 3–4 months, before plaque deposition; loss occurred in CA1, CA3, and dentate gyrus at 3 months but not in striatum, and was not seen at 1 month.
- C1q was elevated in J20 brains as early as 1 month, region-specifically in hippocampus and frontal cortex, and colocalized with PSD95-positive puncta; Compound E reduced soluble Aβ and C1q deposition, while oligomeric Aβ—but not monomeric Aβ or vehicle—induced C1q deposition and synaptic colocalization.
- Oligomeric Aβ induced synapse loss within 72 h in WT mice but not in C1qa knockout mice; anti-C1q antibody ANX-M1 prevented oAβ-induced synapse loss and LTP impairment, and APP/PS1xC3 KO mice did not show the synapse loss seen in 4-month APP/PS1 hippocampus.
- Microglial CD68 increased in J20 hippocampus and after oAβ; oAβ increased internalized Homer-GFP in microglia, failed to do so in CR3 KO mice, and induced hippocampal synapse loss in WT but not CR3 KO mice.
Methods
- Mouse models included J20 hAPP, APP/PS1, C1qa KO, C3 KO, CR3 KO, and Homer-GFP mice, with WT littermates and ages including 1 month, 3–4 months, and P21.
- Synapse quantification used super-resolution structured illumination microscopy, confocal imaging, and electron microscopy with colocalized pre- and postsynaptic puncta markers including synaptophysin/PSD95, synaptotagmin/homer, and synapsin/PSD95; C1q and C3 colocalization with PSD95 was also measured.
- Interventions included Compound E, intracerebroventricular or tail vein injections of soluble Aβ oligomers, monomers, or vehicle, anti-C1q antibody ANX-M1 or IgG control, acute hippocampal slice LTP recordings, and an in vivo synaptic engulfment assay.
Limitations
- The paper states that specific synaptic C1q receptors are not yet known and that oAβ and C1q may act indirectly through cytokines such as TGFβ, microglial or astrocytic activation, or other pathways including MHCI/PirB.
- The paper states that the complement pathway may not be involved in all pathological routes to AD, including plaque-associated synapse loss, and that future studies are needed to examine plaque-associated synapse loss and other synaptopathies such as tauopathies and Huntington’s disease.
- Evident from the text: the findings are from mouse models and acute hippocampal slices, not human AD tissue or clinical trials, and the study focuses on early pre-plaque mechanisms rather than established plaque-associated neuropathology.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
16 Valid · 0 Not valid · 2 Not checked · 48 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“C1q binds synapses in vulnerable regions undergoing synapse loss (our data here; (5, 27)).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [5] Stevens B The classical complement cascade mediates CNS synapse elimination. Cell 2007 131 1164 1178 18083105 source
The Results report C1q localized to synapses in the developing dLGN during synaptic pruning and relocalized to adult retinal synapses in early glaucoma, before significant synapse loss. The Discussion likewise places synaptic C1q relocalization before or concurrent with synapse loss in the glaucoma model. (LLM, conf=0.89)
- Not checked — no full text of the sourcecites [27] Stephan AH Barres BA Stevens B The complement system: an unexpected role in synaptic pruning during development and disease. Annu. Rev. Neurosci 2012 35 369 389 22715882 source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“suggesting that the engulfed synapses are internalized into lysosomal compartments in a manner similar to developmental synaptic pruning (6).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [6] Schafer DP Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner. Neuron 2012 74 691 705 22632727 PMC3528177 source
The Results section, “Microglia engulf RGC inputs during a period of active synaptic pruning” (page unavailable), reports that most engulfed RGC inputs colocalized with microglial lysosomal compartments. The Results section, “Microglia engulf presynaptic elements specific to RGCs” (page unavailable), also identifies an RGC presynaptic marker within microglial lysosomes, supporting the proposed similarity to developmental synaptic pruning. (LLM, conf=0.94)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Quantification of colocalized pre- and postsynaptic puncta (synaptophysin and PSD95 (Fig. 1A); synaptotagmin and homer (figs. S1A-D)) revealed a significant loss of synapses in J20 hippocampus at 3-4 months old (mo), an age that precedes plaque deposition (11, 12).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [11] Mucke L High-Level Neuronal Expression of Abeta 1-42 in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation. Journal of Neuroscience 2000 20 4050 10818140 PMC6772621 source
The citation is attached to the statement that 3–4 months precedes plaque deposition, not to the citing authors’ synapse measurements. In “Effects of hAPP mutations on formation of amyloid plaques” (Fig. 4; page not provided), the paper assesses mice at 2–4 months and reports amyloid deposition in APP Sw,Ind mice at 5–7 months; the paper identifies J20 as an APP Sw,Ind line. (LLM, conf=0.91)
- Supportedcites [12] Hong S Dynamic Analysis of Amyloid -Protein in Behaving Mice Reveals Opposing Changes in ISF versus Parenchymal A during Age-Related Plaque Formation. Journal of Neuroscience 2011 31 15861 15869 22049429 PMC3227224 source
The citation follows the statement that 3–4 months precedes plaque deposition, rather than the citing authors’ own synapse measurements. The Results section (page unavailable) identifies approximately 3-month-old J20 mice as pre-plaque and describes 3–7-month-old mice as plaque-free. (LLM, conf=0.91)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Genome-wide association studies (GWAS) implicate microglia and complement-related pathways in AD (1).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [1] Hong S Dissing-Olesen L Stevens B New insights on the role of microglia in synaptic pruning in health and disease. Curr Opin Neurobiol 2016 doi:10.1016/j.conb.2015.12.004 PMC5479435 26745839 source
The Introduction says GWAS and integrated network studies identify immune-related AD risk pathways implicating microglia. The section on microglia–synapse dysfunction identifies GWAS variants CLU and CR1, both related to complement. Page numbers are not provided in our copy. (LLM, conf=0.93)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“C1q was also similarly increased in hippocampus of another model of AD, the APP/PS1 mice (15) (Fig. S2C).”
§ Complement and Microglia Mediate Early Synapse Loss in Alzheimer Mouse Models > Abstract
What the sources say
- Supportedcites [15] Jankowsky JL Mutant presenilins specifically elevate the levels of the 42 residue beta-amyloid peptide in vivo: evidence for augmentation of a 42-specific gamma secretase. Hum. Mol. Genet 2004 13 159 170 14645205 source
The citation identifies the APP/PS1 mouse model, while the citing document points to its own Fig. S2C for the C1q increase. Figure 2 (p. 4) describes APPswe/PS1 double-transgenic mice and shows hippocampal amyloid pathology in that model. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
48 more claims · 5 with their cited sources checked
Create a free account to see all 66 claims and every source verdict.
- It may state two separate claims as one. 11
- Probably not a substantial claim. 2
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“increasing evidence demonstrate that immune signaling may not just be a consequence of protein aggregation in the brain, but that it actually causes the buildup of aggregates at the earliest stages of the disease process.15–17”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [15]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In neurodegeneration, the complement pathway is activated, and inhibiting the complement proteins C1q or C3 results in less neuroinflammation, Aβ plaques and synapse loss29,30.”
From Exercise plasma boosts memory and dampens brain inflammation via clusterin (2021) · cites this paper as [30]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Before the onset of Aβ deposition, microglia engulf synapses opsonized with the complement factors C1q and C3 upon CR3-mediated recognition of C3 (121).”
From Microglia in Alzheimer's disease (2017) · cites this paper as [121]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Lack of C1q, C3, or CR3 curbed microglia activation and synaptic loss during amyloid plaque deposition.”
From Microglia Function in the Central Nervous System During Health and Neurodegeneration (2017) · cites this paper as [139]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Inappropriate control of the classical complement cascade causes unresolvable inflammation and disease (Hong et al. , 2016; Hansen, Hanson and Sheng, 2018; Morgan, 2018).”
From Spatial Transcriptomics and In Situ Sequencing to Study Alzheimer’s Disease (2020) · cites this paper as Hong et al., 2016
Experimental — accuracy not yet measured
70 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Self-check results appear here once an independent check has confirmed them.
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
In the paper
“It is also plausible that oAβ and C1q may work indirectly to mediate synapse loss through cytokines such as TGFβ (7), through microglial or astrocytic activation, or through other mechanisms including MHCI/PirB, another immune pathway critical for synapse elimination in development and AD (28-30).”
Cited work 10.1038/nn.3560 · retracted 2022-01-13 · notice 10.1038/s41593-021-00877-7 · this paper published 2016-05-06
Citations
Cites
1 retracted
Bialas, A. R., & Stevens, B. (2013) · Nature Neuroscience · doi:10.1038/nn.3560 · Cited by 519 · cited 2×
“It is also plausible that oAβ and C1q may work indirectly to mediate synapse loss through cytokines such as TGFβ (7), through microglial or astrocytic activation, or through other mechanisms including MHCI/PirB, another immune pathway critical for synapse elimination in development and AD (28-30).”
Self-citationRetractedAmyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420 · cited 1×
“Synaptic deficits occur in early AD and mild cognitively impaired patients before onset of plaques and are some of the first signs of the neuronal degenerative process (4, 23-25).”
Self-citationTerry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397 · cited 1×
“The degree of region-specific synapse loss is a stronger correlate of cognitive decline in AD than counts of plaques, tangles and neuronal loss (8, 9).”
Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner
Schafer, D. P., Lehrman, E. K., Kautzman, A. G., Koyama, R., Mardinly, A. R., Yamasaki, R., Ransohoff, R. M., Greenberg, M. E., Barres, B. A., & Stevens, B. (2012) · Neuron · doi:10.1016/j.neuron.2012.03.026 · Cited by 4,089
Self-citationThe Classical Complement Cascade Mediates CNS Synapse Elimination
Stevens, B., Allen, N. J., Vazquez, L. E., Howell, G. R., Christopherson, K. S., Nouri, N., Micheva, K. D., Mehalow, A. K., Huberman, A. D., Stafford, B., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.036 · Cited by 3,313 · cited 4×
“Although specific receptors for C1q at synapses are not yet known, C1q binds synapses in vulnerable regions undergoing synapse loss (our data here; (5, 27)).”
InfluentialSelf-citationIdentification of a unique TGF-β–dependent molecular and functional signature in microglia
Butovsky, O., Jedrychowski, M. P., Moore, C. S., Cialic, R., Lanser, A. J., Gabriely, G., Koeglsperger, T., Dake, B., Wu, P. M., Doykan, C. E., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3599 · Cited by 2,543 · cited 1×
“S11), indicating they are resident cells (22).”
Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376 · cited 1×
“The degree of region-specific synapse loss is a stronger correlate of cognitive decline in AD than counts of plaques, tangles and neuronal loss (8, 9).”
Mucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., & McConlogue, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04050.2000 · Cited by 1,856 · cited 3×
“S4), long before Aβ plaques deposit (11, 12), raising the question of whether C1q increase in these pre-plaque brains is dependent on soluble Aβ levels.”
Jankowsky, J. L., Fadale, D. J., Anderson, J., Xu, G. M., Gonzales, V., Jenkins, N. A., Copeland, N. G., Lee, M. K., Younkin, L. H., Wagner, S. L., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh019 · Cited by 1,575
Cited by
Items 2,601–2,700 of 3,349
Dietz, L. T., Põld, K., Györffy, B. A., Zharkovsky, A., Sørensen, J. B., Pankratova, S., & Dmytriyeva, O. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04475-z · Cited by 2
Sivanesan, S., Howell, M. D., Kaushik, V., Rajadas, J., Pari, S. S., & Goyal, P. (2024) · Current Alzheimer Research · doi:10.2174/0115672050324909240823104209 · Cited by 1
Narayanaperumal, J., & Gopal, G. (2024) · Exploration of Immunology · doi:10.37349/ei.2024.00170 · Cited by 1
Bie, N., Yan, M., & Wang, C. (2025) · Food Science and Human Wellness · doi:10.26599/fshw.2025.9250517 · Cited by 1
Koller, E. J., McFarland, K. N., Angelle, C., Howard, J. C., Ryu, D., Dillon, K. D., Erquizi, A., Beheray, M., Cruz, E. G. D. L., Cruz, P. E., et al. (2025) · Acta Neuropathologica Communications · doi:10.1186/s40478-025-01968-3 · Cited by 2
“While some studies report that suppressing microglial function reduces the pathological burden of AD-associated Aβ and tau [12–14], others have shown that early glial activation mediated by cytokines could have a beneficial effect in preventing or clearing protein aggregates [15–17].”
The Enigmatic Gut-Brain-Immune Trio in Brain and Behavior Disorders
Mythri, R. B. (2025) · Advances in medical diagnosis, treatment, and care (AMDTC) book series · doi:10.4018/979-8-3693-7432-0.ch019 · Cited by 1
Neuroglial responses to bacterial, viral, and fungal neuroinfections
Awogbindin, I. O., Šimončičová, E., Vidal, V., Ash, C., & Tremblay, M. (2025) · Handbook of clinical neurology · doi:10.1016/b978-0-443-19102-2.00027-2 · Cited by 1
Features of cognitive impairments and their pathogenesis in patients with long COVID-19
Shulga, O. D., Korniichuk, Y. V., Fedotova, T. V., & Skrypka, M. P. (2025) · Psychiatry Neurology and Medical Psychology · doi:10.26565/2312-5675-2025-28-10 · Cited by 1
Calycosin improved long-term memory impairment in the very early of APP/PS1 mice
Ding, Z., Wang, J., Ding, W., Duan, Y., Qi, F., Liu, J., Liu, J., & Jiang-bi, W. (2025) · Brain Research · doi:10.1016/j.brainres.2025.149789 · Cited by 2
Keshvari, M., Heidarianpour, A., & Chehelcheraghi, F. (2025) · Scientific Reports · doi:10.1038/s41598-025-08414-3 · Cited by 2
Bezerra, I. C., dos Santos, E. R. S., do Nascimento, K. G. A., da Silva, A. J., de Farias, J. B., Vitorino, M., da Silva, R. A., Filho, J. L. D. L., & Gubert, P. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70152 · Cited by 3
“The pathophysiology in neuronal tissue comprises increased Aβ deposits generating mitochondrial damage, oxidative stress, synaptic dysfunction, and decreased aerobic respiration, among others (Gao et al. 2020; Fani et al. 2021; Hong et al. 2016; Kugler et al. 2024).”
A bibliometric analysis of the immune system and cognitive impairment: trends from 1985 to 2024
Zou, B., Xiang, J., Zhang, M., Huang, J., & Feng, C. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1587575 · Cited by 3
Microglia-mediated cognitive impairment induced by methamphetamine
Izuo, N., Kusui, Y., & Nitta, A. (2025) · Folia Pharmacologica Japonica · doi:10.1254/fpj.25032 · Cited by 2
Li, Y., Xu, X., Tang, L., & Initiative, O. B. O. T. A. D. N. (2025) · Frontiers in Neurology · doi:10.3389/fneur.2025.1629389 · Cited by 2
“In addition, emerging finding from both animal models and human brains study, indicates the synaptotoxic role of amyloid deposition and microglia-induced neuroinflammation (22, 23).”
InfluentialThapa, R., Adhikari, N., Gautam, S., Sun, M., McOmie, S., Davydzenka, V., SMITH, D. R., Syring, J., Kaligis, H., Kosmicki, J. M., et al. (2025) · iScience · doi:10.1016/j.isci.2025.113745 · Cited by 2
“68–70 We performed co-immunostaining of B2M and C4b with Olig2, an oligodendrocyte marker (Figures S10D and S10E).”
Lemmik, H., Kim, E., MacNicol, E., Maselli, D., Bernanos, M., Li, Z., Abdullahi, D., Walters, E. H., Navacerrada, M. E. S., Zhou, W., et al. (2025) · Brain Communications · doi:10.1093/braincomms/fcaf422 · Cited by 1
Key features of the innate immune response is mediated by the immunoproteasome in microglia
Izadjoo, S., Moritz, K. E., Khayrullina, G., Bergman, E. M., Melvin, B. M., Stinson, M. W., Paulson, S. G., McCormack, N. M., Anderson, K. N., Lewis, L. A., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-25341-5 · Cited by 2
“Contrary to this, several studies have suggested that phagocytosis may exacerbate neuronal death during inflammation, promoting neurodegeneration 43–47 .”
Tkach, V. V., Bager, N. S., Michaelsen, S. R., Litman, T., Josefsen, K. E., Kristensen, B. W., Lund, E. L., & Areškevičiūtė, A. (2025) · Acta Neuropathologica Communications · doi:10.1186/s40478-025-02163-0 · Cited by 1
“…of pathological proteins can chronically maintain microglia in this reactive state that consequently impairs the clearance of the proteins and leads to persistent production of neurotoxic molecules that accelerate neurodegeneration, both directly and in the interaction with astrocytes [34, 53, 55].”
Xu, L., Zhou, Y., Yang, H. K., Chen, X., & Ouyang, Q. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115596 · Cited by 2
Mapping microglial mechanisms in Alzheimer’s disease: a comprehensive analysis
Wang, X., Guo, Y., Zha, Y., Wang, S., Yang, W., & Jia, Q. (2025) · Experimental Biology and Medicine · doi:10.3389/ebm.2025.10808 · Cited by 1
Batista, A. F., Presumey, J., Singh, B. B., Yalçın, E., Schroeder, M. K., Khan, K., Spooner, E., Li, S. A., Carroll, M. C., & Lemere, C. A. (2025) · Molecular Neurodegeneration Advances · doi:10.1186/s44477-025-00010-z · Cited by 4
“Studies in rodent models have implicated the classical complement pathway in pathological synaptic loss processes[26, 27, 55].”
InfluentialSelf-citationOu, H., Chen, R., Zhou, L., Zhang, Y., Zhao, S., & Yang, Z. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.116097 · Cited by 1
Viral modulation of synaptic pruning: implications for neuropathology and brain function
Aliakbari, S., Asadi, S., Sayyah, M., Naderi, N., Salarvandian, S., Khodagholi, F., & Pourbadie, H. G. (2026) · Journal of Virology · doi:10.1128/jvi.01684-25 · Cited by 5
“…herpes simplex, coronavirus disease 2019 (COVID-19), and human immunodeficiency virus (HIV) (4), alter synaptic transmission and contribute to aberrant synaptic pruning in the brain through alteration of gene expression, synaptic proteins, and regulation of proinflammatory cytokines (13, 15).”
Matamoros, J. A., Salobrar‐García, E., Salazar, J. J., López‐Cuenca, I., Elvira‐Hurtado, L., Martínez‐López, M. A., Rubio‐Casado, S., Paleo‐García, V., de Hoz, R., Ramirez, J. M., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27021012 · Cited by 2
“At day three, intense glial activation is evident in this model [56,58], and microglial activation in neurodegenerative contexts is known to trigger pro-inflammatory cytokine release and complement system activation, leading to synaptic pruning even before neuronal death [80].”
Roles of Glia in Synapse Nano-organization
Choi, Y., & Chung, W. (2026) · Advances in neurobiology · doi:10.1007/978-3-032-12594-1_11 · Cited by 2
Adrenergic signaling during parasitic infections
Gardias, P., & Bąska, P. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1691005 · Cited by 1
Ferro, A., Vita, D. J., Fallon, T., Arshad, A., Boyd, L., Stanley, T., Lin, Q., Berisha, A., Vrudhula, U., Gomez, A. M., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.116926 · Cited by 1
“Interestingly, among the TNFR superfamily members included in the study from Pollina et al., 27 9 of the 18 genes encoding TNFRs exhibited either a significant upregulation (6 genes) or downregulation (3 genes) following kainate exposure compared to vehicle-treated controls (Figure S1O).”
Cui, J., Shen, F., Zhang, C., Fu, C., Zhu, J., & Zhuang, T. (2026) · Pathology - Research and Practice · doi:10.1016/j.prp.2026.156386 · Cited by 3
Agrin at the crossroads of aging: A pleiotropic regulator in age-related diseases
Yuan, J., Zhang, S., Han, D., & Dong, X. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.108131 · Cited by 5
Meftah, S., Wilson, M. A., Elliott, J., McLay, L., Dobrovolskis, V., Rosencrans, S., Taylor, L. W., Mugnaini, C., Mostallino, R., Durrant, C. S., et al. (2026) · eNeuro · doi:10.1523/eneuro.0099-23.2025 · Cited by 2
“This con fi rms consistency with other studies in the APP/PS1 mouse where synaptic loss has been reported (Knafo et al., 2009; Alonso-Nanclares et al., 2013; Hong et al., 2016; Oyelami et al., 2016; Viana da Silva et al., 2016).”
Zheng, D., Gu, J., Nao, J., Sun, M., & Dong, X. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03727-0 · Cited by 1
Li, Y., Cheng, Q., Tian, S., Li, X., Chen, Y., Guo, Y., Jiang, Y., Tao, Y., Niu, X., Hu, H., et al. (2026) · Phytotherapy Research · doi:10.1002/ptr.70185 · Cited by 1
“…neurodegenerative disorder clinically characterized by cognitive decline and pathologically defined by extracellular Aβ plaques, intracellular neurofibrillary tangles (NFTs), sustained neuroinflammation, and pronounced neuronal loss (Heneka et al. 2024; Holmes et al. 2008; Hong et al. 2016).”
Self-citationLi, H., Li, M., Li, C., Liu, D., Kang, Y., Tang, Y., Feng, P., & Qian, C. (2026) · ACS Nano · doi:10.1021/acsnano.6c00812 · Cited by 3
Yin, W.-M., He, L.-C., Zhu, H., Cao, Y., Li, A.-M., Wang, Y.-C., & Xu, Y.-M. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116407 · Cited by 1
Neuroinflammation as a driver of Down syndrome-associated Alzheimer’s disease
Qu, H., Snorradóttir, Á. Ó., Gutierrez-Uzquiza, A., Kao, C., March, M., & Hakonarson, H. H. (2026) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2026.106513 · Cited by 2
Wang, Z., lyu, D., Xiang, Y., Lu, Y., Yu, T., Zhou, W., Wu, M., Yin, X., & Chen, Z. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116381 · Cited by 1
Cross-Organ Neuroimmunology of Behavior
Guo, X., & Russo, S. J. (2026) · Annual Review of Immunology · doi:10.1146/annurev-immunol-082924-064159 · Cited by 2
Microglial Senescence in Neurodegenerative Diseases: Mechanisms and Therapeutic Perspectives
Liu, Y., Hu, Z., Xiao, Y., Han, X., Cheng, X., & Ye, T. (2026) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6c00016 · Cited by 1
Dai, Y.-T., Chen, Q., Ma, Y.-D., Liu, H., Zheng, H., Zhu, Y.-Y., Gao, L., Zhao, Q., Bai, J.-L., Fan, Y.-C., et al. (2026) · Neuropharmacology · doi:10.1016/j.neuropharm.2026.110887 · Cited by 2
Gaudet, A. D., & Fonken, L. K. (2026) · Trends in Neurosciences · doi:10.1016/j.tins.2026.01.002 · Cited by 6
Harper, M. M., Jones, M.-G., Gramlich, O. W., Elwood, B. W., Boehme, N., Gilfanov, N., Dutca, L. M., & Kuehn, M. H. (2026) · Experimental Eye Research · doi:10.1016/j.exer.2026.110961 · Cited by 1
Zhang, Y., Qian, X., Zhuang, H., Zhang, W., Hu, J., Zhao, Y., Li, Y., Jin, W., Xu, C., Meng, Z., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71229 · Cited by 2
“9,10 Previous positron emission tomography (PET) studies with the 18-kDa translocator protein (TSPO) radioligands revealed the biphasic roles of microglial activation in AD.”
Pang, C., Sun, X., Zhao, J., Liang, X., Sun, L., Lin, Q., Sun, J., Lu, X., Dong, Q., Zhang, L., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2519586123 · Cited by 5
“An animal study demonstrated that abnormal frontal cortex activity— part of the FPN—is associated with excessive synaptic pruning (38), a process associated with cognitive decline and accelerated brain aging (39).”
TREM2 as a possible link between Alzheimer's disease and diabetes mellitus
Chen, W., Huang, N., Huang, W., Wang, M., Luo, Y., & Huang, J. (2026) · Experimental Neurology · doi:10.1016/j.expneurol.2026.115739 · Cited by 3
Llovera, G., Heindl, S., Varga, D. P., Lénárt, N., Kallabis, S., Göb, V., Stegner, D., Escaig, R., Nicolai, L., Franzmeier, N., et al. (2026) · EMBO Molecular Medicine · doi:10.1038/s44321-026-00397-6 · Cited by 1
“EV4 and 5), we decided to investigate the two main functions of microglial cells already described in the literature, neuronal surveillance (Cserep et al, 2020) and synapse pruning (Hong et al, 2016).”
Sleep Disorders in Neurodegenerative Diseases: Pathological Correlations and Underlying Mechanisms
Wang, Z., He, F., Li, L., Wang, W., Zhang, L., Tang, J., & Le, W. (2026) · Neuroscience Bulletin · doi:10.1007/s12264-026-01609-2 · Cited by 3
“This mechanism of phagocytosis-mediated synapse elimination offers a mechanistic explanation for the cognitive deficits and memory loss observed in sleep-deprived individuals [135, 136].”
Interactions between Innate Immune Memory and the Central Nervous System
Valerio, R. R., Bernardi, A., Bonomo, A., & Frozza, R. L. (2026) · NeuroImmunoModulation · doi:10.1159/000551784 · Cited by 1
Noninvasive Terahertz Wave Binocular Stimulation Improves Cognition in Amyloid-β-Related Dementia
Wu, H., Zhang, T., Ma, J., Yin, J., Liu, J., Lin, H., Yu, Y., He, Y., Cheng, W., Song, Z., et al. (2026) · Research · doi:10.34133/research.1268 · Cited by 2
“S1 B), consistent with astrocyte activation and neuronal injury [ 34 ].”
Li, Y., Wu, H., Yang, J., Weedor, J. G., Ding, H., Cui, W., Cui, B., He, Z., Zhang, W., Xing, Y., et al. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03761-y · Cited by 2
“Notably, we provide evidence that reshaping the composition of gut microbiota is attributed to the protective effects of C. butyricum on TNDs. Neuronal or synaptic impairment is a hallmark of neurodegeneration [56, 57].”
Partners in plasticity: serotonergic glial interactions in brain circuit remodeling
Miller, V. K., & Broadie, K. S. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1782246 · Cited by 3
Trigo-Alonso, P., Luengo, E., Fernández‐Mendívil, C., Viqueira, L., García‐Magro, N., del Sastre, E., Bernal, J. A., Negredo, P., & López, M. G. (2026) · Acta Neuropathologica Communications · doi:10.1186/s40478-026-02291-1 · Cited by 1
“C1q and postsynaptic density protein 95 (PSD95) associated puncta analyses was performed using a 63 × objective and he Plug in “Puncta Analyzer” in ImageJ (https:/ /imagej .net/co ntri bute/citing) version 1.26 as reported in [13].”
InfluentialLv, S., Kuang, J.-Y., Wang, T.-W., Zhang, L.-P., Liu, J., Wang, W., Yang, M.-F., Ni, Q., Sun, B.-L., & Sun, J.-Y. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1648591 · Cited by 1
The Roles of Macrophage Lineage Cells ( MLC s) in Brain Aging
Qin, Q., Zhang, L., Guo, M., Lu, D., Liu, Y., Wang, Z., Hu, M., Wang, S., Kang, X., Yi, H., et al. (2026) · CNS Neuroscience & Therapeutics · doi:10.1002/cns.70873 · Cited by 1
“This aberrant process is largely driven by the age-related reactivation of the complement cascade, specifically the deposition of C1q and C3 on synapses, which tags them for excessive en-gulfment [18].”
Nagata, W., & Ishizuka, T. (2026) · Human Cell · doi:10.1007/s13577-026-01381-5 · Cited by 1
Type-1 interferons associated with microglial-mediated neuroinflammation in Alzheimer’s disease
Shippy, D. C., Sande, M. L., & Ulland, T. K. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03828-w · Cited by 4
“On the other hand, microglia are directly linked to early synapse loss, and several studies show microglia transport phagocytized tau and Aβ to unaffected regions of the brain, facilitating the spread of plaques [17–20].”
Ferreira, A. F. F., Feng, Z., Sun, H., & Britto, L. R. (2026) · Acta Pharmacologica Sinica · doi:10.1038/s41401-026-01797-7 · Cited by 1
Geraghty, J. R., Katz, E. A., Butler, M. P., & Testai, F. D. (2026) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000200582 · Cited by 1
A comparison of deep multiomics profiles across ethnicity, geography, and age
Bararpour, N., Cao, J. Z., Wu, Y., Gupta, S., Hoopmann, M. R., Qin, R., Midha, M. K., Mireault, M., Juanes‐Velasco, P., Hanson, C. R., et al. (2026) · Cell · doi:10.1016/j.cell.2026.04.032 · Cited by 5
Tian, M., Wang, D., Zhang, C., Fan, J., Li, W., Liu, X., & Shi, J. (2026) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6c00173 · Cited by 6
Edwards, N., Sakata, S., McConnell, G., & Bushell, T. J. (2026) · Neuropharmacology · doi:10.1016/j.neuropharm.2026.111010 · Cited by 1
Gong, S., Chen, Y., Su, L., 姚恩生, Li, Z. L., Liu, X., & Li, S. (2026) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2026.101264 · Cited by 1
“In addition, microglia have been shown to engulf synaptic material through a CR3-dependent pathway in the presence of soluble A β oligomers, highlighting their capacity to directly regulate synaptic structure under pathological conditions (Hong et al., 2016).”
Self-citationTian, M., Feng, R., Gong, C., Ben, X., Ma, Z., Yi, X., & Guo, Q. (2026) · Biomolecules · doi:10.3390/biom16060798 · Cited by 2
“Given the established role of the cytokine–microglia– complement axis in synaptic vulnerability and cognitive impairment in AD, its attenuation may provide a plausible link between EV-associated transcriptomic remodeling and improved hippocampal function [43].”
Li, E., Zhang, P., & Feng, W. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1783786 · Cited by 6
“Complement also connects glial crosstalk with synaptic vulnerability, because complement and microglia mediate early synapse loss in AD mouse models (50).”
Huang, Y. S., Xie, X., Huang, Z., Gangal, H., Chen, R., Wang, X., Li, J., & Wang, J. (2026) · Neuropharmacology · doi:10.1016/j.neuropharm.2026.111069 · Cited by 6
Microglial ITAM & ITIM Signaling in Neurodegenerative Disease and Brain Aging
Mangalmurti, A., Bonheur, A., & Lukens, J. R. (2026) · Journal of Molecular Biology · doi:10.1016/j.jmb.2026.169910 · Cited by 2
García-Peña, P., Ramos, M., López, J. M., Martínez‐Murillo, R., de Arcas, G., & González‐Nieto, D. (2026) · Neurobiology of Disease · doi:10.1016/j.nbd.2026.107484 · Cited by 2
Özata, G., Wise, R. M., Cardona‐Alberich, A., Mayeen, N. F., Müller, S. A., Lichtenthaler, S. F., Zecca, L., & Burbulla, L. F. (2026) · Scientific Reports · doi:10.1038/s41598-026-55648-w · Cited by 1
“…trafficking and complement regulation suggesting impaired microglial clearance of apoptotic material and protein aggregates – a hallmark of microglial dysfunction in neurodegenerative diseases 75,76 and a process critical for maintaining CNS homeostasis and preventing inflammation 1,41,77 .”
Glucose metabolic reprogramming: mechanisms and therapeutic implications in neuroinflammation
Zhang, L., Yang, X., & Ai, X. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1737175 · Cited by 2
Xing, J. F., Mu, K., Xue, Y., Yang, X., Zhang, D., Gao, W., Zhang, T., Yang, S., Wang, R., Zhang, W., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1843978 · Cited by 2
“Synaptic loss is an early, clinically relevant feature of AD, affecting the hippocampus and entorhinal cortex (33, 82).”
InfluentialMikołajczak, K., Chmiel, J., & Leszek, J. (2026) · Cells · doi:10.3390/cells15121111 · Cited by 3
“…[167,169] Predominance of immunosuppressive M2 phenotype [142,170] Pro-inflammatory cytokines ↑ IL-1 β , TNF-α and other inflammatory mediators [14,176] ↑ IL-1 β , TNF-α and tumor-promoting cytokines [164,176] Inflammasome activation Promotes IL-1 β release, ASC speck formation, and…”
InfluentialKumar, N., Mir, P. A., Bhutia, G. T., Chaudhary, P., Kaur, G., Alam, Q., Pawar, S. D., & Gupta, S. K. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05983-w · Cited by 1
Inflammation profiles in Alzheimer's disease relate to cognition and neurodegeneration
Birditt, K. R., Mavromati, K., Swann, P., Quinn, T., Hainsworth, A. H., Hughes, L., O'Brien, J. T., McEwan, W. A., & Malpetti, M. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.71642 · Cited by 4
“Inflammation’s effects on clinical outcomes have been suggested to be partially mediated by neuroaxonal damage, 13 which can be proxied by plasma neurofilament light (NfL) levels.”
Quach, B., Salehi, S. N., Roufegarinejad, R., Guleria, V. S., Mante, M., Florio, J. B., Rissman, R. A., & Winston, C. N. (2026) · Experimental Neurology · doi:10.1016/j.expneurol.2026.115893 · Cited by 2
Antibodies sculpt adult brain circuits
Miarka, L., & Prinz, M. (2026) · Science · doi:10.1126/science.aei8076 · Cited by 1
Lan, Y.-C., Xiao, Y., Hsieh, Y., Cheng, Y., Peng, S., Chueh, F., Lee, H.-T., HSIEH, Y.-S., Jiang, W.-C., Hsieh, W., et al. (2026) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2026.117942 · Cited by 1
Zou, M., Zhao, T., Wu, W., Zhang, J. Y., Pan, P., Yan, J., Li, Q., & Zhou, Y. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03946-5 · Cited by 2
“Mitoph-agy impairment may favor a shift from a homeostatic state toward a pro-inflammatory state, accompanied by increased expression of complement factors C1q and C3 [123].”
Petrisko, T. J., Chu, S., Gómez-Arboledas, Á., Zhang, B., & Tenner, A. J. (2026) · Glia · doi:10.1002/glia.70189 · Cited by 7
“…Tenner and Petrisko 2025), and activation of C1 and C3 has also been implicated in AD as a mechanism of synaptic loss and cognitive impairment (Hong et al. 2016; Wu et al. 2019), with constitutive knockouts of C1q restoring synaptic density and reducing pathology in both tauopathy (Dejanovic…”
Khan, M. S., Zafar, I., & Bopassa, J. C. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27146329 · Cited by 3
Zaman, W., Ayaz, A., & Ullah, A. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.118275 · Cited by 3
Azimzadeh, M., & Azimzadeh, M. (2026) · Behavioural Brain Research · doi:10.1016/j.bbr.2026.116404 · Cited by 2
Hu, Y., Chen, H., Zhao, J., Wang, J., Chen, J., Luo, W., & Zhang, J. (2026) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2026.143120 · Cited by 2
Wang, Q.-Q., Sun, Q.-Q., Guo, Y.-S., Yin, S., & Zhou, J. (2026) · Translational Neurodegeneration · doi:10.1186/s40035-026-00571-3 · Cited by 2
Jiao, Y., Zhu, Z., Wang, R., He, B.-Y., Yao, H., Zhi-yong, Z., Shi, Y.-F., Wang, C., Cao, L., Liu, Y., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117749 · Cited by 2
Li, S., Jin, J., Liu, Y., Yuan, J., Dong, Y., Wang, Z., Lu, L., & Zhang, Y. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261469862 · Cited by 2
“36 Conversely, chronically activated microglia can release IL-1 β , IL-18, ROS, nitric oxide and complement-related mediators, 37,38 thereby aggravating synap-ticinjury, 39 neuronalmitochondrialdysfunction,andtau-related pathologicalpropagation.”
Self-citationAli, S., Ayaz, A., & Zaman, W. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.118343 · Cited by 1
Alghamdi, H. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103322 · Cited by 2
Ling, Z., Huang, S., Cheng, Y., Liu, X., Xu, X., Chen, Y., Hu, P., Wu, L., & Cai, G. (2026) · Current Research in Microbial Sciences · doi:10.1016/j.crmicr.2026.100660 · Cited by 2
“Complement-mediated synaptic pruning, while essential for normal brain development and plasticity, becomes pathologically exaggerated in AD (Hong et al., 2016; Stevens et al., 2007).”
Synapse engineering: A new level of brain modulation
Chen, Y., & Geng, Y. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.10.003 · Cited by 1
“1, PKCα and the complement cascade, etc (Alfonso et al., 2016; Hong et al., 2016; Sheng et al., 2012; Verret et al., 2012).”
Stephens, G. S., You, J. C., Fu, C.-H., & Chin, J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809324-5.21126-7 · Cited by 1
Neuroprotection in Perimenopausal Women
Russu, M. C., & Antonescu, A. C. (2018) · InTech eBooks · doi:10.5772/intechopen.74330 · Cited by 3
“The shift is connected to proinflammatory cytokines and oxidative-nitrosative stress, which plus elevated levels of complement pathway components and other immune factors plays a key pathophysiological role in promoting cognitive dysfunction by enhancing endothelin, Amyloid-β deposition, cerebral amyloid angiopathy, a…”
BackgroundCurrent and Future of Alzheimer's Therapy with the Best Approach
Singh, H., Chawla, V., Bala, R., & Dureja, H. (2020) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527319666200430000538 · Cited by 2
WNT vampirization by glioblastoma leads to tumor growth and neurodegeneration
Portela-Esteban, M., Venkataramani, V., Fahey-Lozano, N., Seco, E., Losada‐Pérez, M., Winkler, F., & Casas‐Tintó, S. (2018) · Figshare · doi:10.26181/6004ef260c4d4 · Cited by 1
Glutamatergic Transmission and Synaptopathies
Benarroch, E. E. (2021) · Oxford University Press eBooks · doi:10.1093/med/9780190948894.003.0017 · Cited by 2
The Effect of Systemic Inflammation on Cognitive Function and Neurodegenerative Disease
Cunningham, C. M., & Skelly, D. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108539623.010 · Cited by 1
Development of early biomarkers of Alzheimer's disease: A precision medicine perspective
Sarkar, S., Das, N., & Sambamurti, K. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824010-6.00006-x · Cited by 2
Adaptable toolbox to characterize Alzheimer’s disease pathology in mouse models
Huang, Y., & Lemke, G. (2022) · STAR Protocols · doi:10.1016/j.xpro.2022.101891 · Cited by 1
Pang, Y., Zhu, S., Xu, J., Su, C., Wu, B. Y., Zhang, C., & Gao, J. (2023) · Advanced Biology · doi:10.1002/adbi.202200321 · Cited by 4
New Insights into Microglia as Therapeutic Targets in Alzheimer’s Disease
Mandlik, D. S., Mandlik, S. K., & Choudhary, H. B. (2023) · Current Drug Therapy · doi:10.2174/1574885518666230427100702 · Cited by 2
Mancini, A., Bellingacci, L., Canonichesi, J., & Filippo, M. D. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-85841-0.00017-1 · Cited by 1
Niu, M., & Zong, C. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01697-y · Cited by 1
“As a result, we pinned down the most vulnerable pathways to the synapses, such as the complement-mediated synaptic pruning [3].”
Background
Metadata
- Authors
- Hong, S., Beja-Glasser, V. F., Nfonoyim, B. M., Frouin, A., Li, S., Ramakrishnan, S., Merry, K. M., Shi, Q., Rosenthal, A., Barres, B. A., Lemere, C. A., Selkoe, D. J., & Stevens, B.
- Affiliations
- Boston Children's Hospital (US)
- Brigham and Women's Hospital (US)
- University of California, San Francisco (US)
- Stanford Medicine (US)
- Broad Institute (US)
- Corresponding author
- Beja-Glasser, Victoria F.
- Nfonoyim, Bianca M.
- Stevens, Beth
- ORCID
- Venue
- Science
- Published
- 2016-05-06
- Volume
- 352
- Issue
- 6286
- Pages
- 712-716
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC5094372
- OpenAlex
- W2314634699
- Cited by
- 3,343
- References
- 33
- Citations by year
- 2026: 415 · 2025: 391 · 2024: 384 · 2023: 388 · 2022: 324 · 2021: 363 · 2020: 306 · 2019: 260 · 2018: 240 · 2017: 198 · 2016: 69
- FWCI
- 140.04
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Edward R. and Anne G. Lefler Fellowship
- Coins for Alzheimer's Research Trust
- Fidelity Biosciences Research Initiative
- JPB Foundation
- National Institutes of Health (AG000222)
- National Institute of Neurological Disorders and Stroke-NIH (R01NS083845)
- National Institute on Aging-NIH (1RF1AG051496A)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- Alzheimer's disease, synaptic loss, complement system, microglia, C1q, CR3, complement C3, soluble amyloid-beta oligomers, neuroinflammation, synaptic pruning, hippocampal long-term potentiation, phagocytosis, mouse model
- MeSH terms
- Disks Large Homolog 4 Protein, Alzheimer Disease, Animals, Cognition Disorders, Complement Pathway, Classical, Disease Models, Animal, Membrane Proteins, Phagocytosis, Synapses, Up-Regulation, Complement C1q, Macrophage-1 Antigen, Amyloid beta-Peptides, Synaptophysin, Microglia, Long-Term Potentiation, Mice, Knockout, Mice, Guanylate Kinases, CA1 Region, Hippocampal, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.